PRESS RELEASE published on 07/18/2024 at 07:30, 1 year 4 months ago Nicox Provides Second Quarter 2024 Update Nicox reports €1.6M revenue & €7.8M cash for Q2 2024, extending funds until Feb 2025. Focus on NCX 470 development & Denali trial progress. New Board members appointed Revenue Cash Position Nicox NCX 470 Denali Trial
BRIEF published on 07/16/2024 at 07:35, 1 year 4 months ago Nicox appoints Damian Marron Chairman of the Board of Directors Board Of Directors Ophthalmology Nicox Marc Le Bozec Damian Brown
PRESS RELEASE published on 07/16/2024 at 07:30, 1 year 4 months ago Nicox appoints experienced biotech leader Damian Marron as Chair of the Board and Marc Le Bozec as Director Nicox appoints Damian Marron as Chair of the Board and Marc Le Bozec as Director. Experienced leaders join Nicox Board, Labbe and Kaplan step down. Strategic shift in leadership Board Of Directors Healthcare Nicox Damian Marron Marc Le Bozec
BRIEF published on 06/19/2024 at 07:35, 1 year 5 months ago Nicox succeeds in its capital increase of 3.3 million euros Increase In Capital Ophthalmology Nicox NCX 470 Ocumension Therapeutics
BRIEF published on 06/03/2024 at 07:35, 1 year 6 months ago Nicox SA Announces Voting Rights as of May 31, 2024 Euronext Growth Paris Share Capital Voting Rights AMF Nicox
PRESS RELEASE published on 06/03/2024 at 07:30, 1 year 6 months ago Number of voting rights as of May 31, 2024 Nicox SA monthly publication of the number of shares and voting rights. Details on market, ISIN code, and company's lead programs Voting Rights Shares Ophthalmology Monthly Publication Nicox SA
BRIEF published on 05/31/2024 at 07:35, 1 year 6 months ago Nicox is hosting a webcast for its shareholders on June 6, 2024 Shareholders Webcast Increase In Capital Ophthalmology Nicox
BRIEF published on 05/24/2024 at 07:35, 1 year 6 months ago Nicox: 2024 Ordinary Shareholder Meeting Scheduled for June 28th 2024 Shareholder Meeting Voting Process Ophthalmology Nicox
PRESS RELEASE published on 05/24/2024 at 07:30, 1 year 6 months ago Nicox: 2024 Ordinary Shareholder Meeting to be held on June 28th, 2024 Nicox convenes its 2024 Ordinary Shareholder Meeting on June 28th, 2024, in Sophia Antipolis, France. Shareholders can vote in person, by proxy, or online Shareholder Voting Nicox 2024 Ordinary Shareholder Meeting June 28 2024 Ophthalmology Company
Published on 12/05/2025 at 02:35, 3 hours 49 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 24 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 19 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 24 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 54 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 33 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 59 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 9 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 14 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 24 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 39 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 40 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 23 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
